Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07063056 · ClinicalTrials.gov registry record · NA
Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
A NA study of Triglycerides, sponsored by Medinutra.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT07063056 is a NA study of Triglycerides that is actively recruiting participants, run by Medinutra. The registered enrollment target is 64 participants, roughly in line with the 70-participant average among 4 other Triglycerides trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT07063056, a NA study of Triglycerides, is actively recruiting participants, sponsored by Medinutra.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Astaxanthin
- OTHER Placebo Control
- DIETARY_SUPPLEMENT Curcumin (Longvida™)
- DIETARY_SUPPLEMENT Half Dose Curcumin (Longvida™)
Study Locations (1)
Ohio
- Medinutra LLC - Dublin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-07-18 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07063056
The ClinicalTrials.gov registry entry for NCT07063056 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 70-participant average among 4 other Triglycerides trials with a reported enrollment target. The listed sponsor is Medinutra, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Triglycerides appearing as the primary indexed condition, and to 4 interventions - of which Astaxanthin is the first listed.
NCT07063056 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07063056 about?
NCT07063056 is a clinical study titled "Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation". Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of eithe...
What is the current status of trial NCT07063056?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-07-18. Estimated completion is 2025-12.
What conditions does trial NCT07063056 study?
This clinical trial studies the following conditions: Triglycerides.
What interventions are being tested in trial NCT07063056?
The interventions under investigation include: Astaxanthin (DIETARY_SUPPLEMENT), Placebo Control (OTHER), Curcumin (Longvida™) (DIETARY_SUPPLEMENT), Half Dose Curcumin (Longvida™) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07063056?
This trial is sponsored by Medinutra, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07063056 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Triglycerides
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
RECRUITING · NA
-
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
COMPLETED · Phase 2
-
Effect of Diet on Vascular Disease in Pre-Menopausal Women
COMPLETED
-
Identifying Risk for Diabetes and Heart Disease in Women
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.